PSMA-PET/CT identifies 'atypical' metastases in prostate cancer patients
AuntMinnie
MARCH 21, 2025
PET/CT scans with an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients, researchers have reported. A team led by radiologists in Nairobi, Kenya, found metastases in supraclavicular (SC) lymph nodes in 8% of a large group of patients, and the group suggested adding consideration of the site during the initial diagnostic workup of patients.
Let's personalize your content